Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands out as a key player in the biotechnology sector, offering innovative solutions in nucleic acid production and biologics safety testing. With a market..
Valneva SE (NASDAQ: VALN), a French biotechnology firm specializing in the development and commercialization of prophylactic vaccines, is capturing investor attention with its robust pipeline and promising potential upside. Despite..
Bicycle Therapeutics plc (NASDAQ: BCYC) is a United Kingdom-based biotech company that has captured the attention of investors with its innovative approach to developing a new class of medicines. Specializing..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands out in the biotechnology sector with a remarkable 315% potential upside, according to analyst ratings. This potential is particularly noteworthy given the company’s current..
Xencor, Inc. (NASDAQ: XNCR) is making waves in the biotechnology sector with its innovative approach to developing engineered monoclonal antibodies for a range of challenging diseases, from cancer to autoimmune..
Neuropace, Inc. (NPCE) has captured the attention of healthcare investors, particularly those focusing on the medical device sector. Operating out of Mountain View, California, Neuropace is at the forefront of..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company headquartered in Rockville, Maryland, is making waves in the healthcare sector, particularly in the field of gene therapy. With a market capitalization..
Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is capturing investor attention with a significant potential upside of 17.87% and a compelling dividend yield of 4.24%. This medical..
Auna S.A. (AUNA), a prominent player in the healthcare sector, is capturing investor attention with its substantial upside potential. Based in Luxembourg, Auna operates a network of hospitals and clinics..
OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector as a leader in pediatric orthopedic medical devices. With a market capitalization of $427.76 million, this Indiana-based company has carved..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is an intriguing player in the biotechnology sector, attracting investors with its significant potential upside of 236.05%. Headquartered in San Diego, California, Capricor is a..
Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, is garnering attention with its robust revenue growth of 38.60% over the past year. This specialty and..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology sector with its innovative approach to treating chronic endocrine and neurological diseases. With a market capitalization of..
Community Health Systems, Inc. (NYSE: CYH) stands as a significant player in the U.S. healthcare sector, specifically within the medical care facilities industry. Headquartered in Franklin, Tennessee, the company has..
GH Research PLC (NASDAQ: GHRS) is capturing the attention of investors in the biotechnology space with its compelling potential upside of 134.32%. As a clinical-stage biopharmaceutical company based in Dublin,..
STAAR Surgical Company (NASDAQ: STAA) operates within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Lake Forest, California, STAAR Surgical specializes in designing, developing, and..
CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with a striking potential upside of 71.78%, as suggested by its average target price of $19.43. This figure is particularly compelling for..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a promising player in the biotechnology sector, is capturing investor attention with its robust potential upside of 93.43%. This clinical-stage biopharmaceutical company is focused on..
Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its focus on developing innovative treatments for cystic fibrosis (CF). With a..
